fund management’s performance shall come into force as from 1 January 2015; (2) the second paragraph of Clause 34 relating to fundamental recommendation regarding the importance of basic asset allocation

1,441 million from the assessment of the fair value of net assets and allocation of business acquisition costs, in which if the amortization expenses was still to be included, amounting Baht 360 million

Quarterly Ending March 31, 2018 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 2/2018 dated May 10, 2018

advisor and extraordinary general meeting of shareholders. Management benefit expenses In Q1/2018, the management benefit was Baht 4.35 million compare with the same period of previous year amount to Baht

of Thailand The Board of Directors meeting of KGI Securities (Thailand) Plc (“the Company”), No.1/2019, held on 20th February 2019, approved the audited financial statements, including the consolidated

and Analysis for Year Ending December 31, 2018 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 1/2019

Exchange of Thailand The Board of Directors meeting of KGI Securities (Thailand) Plc (“the Company”), No.1/2020, held on 19th February 2020, approved the audited financial statements, including the

Discussion and Analysis for Year Ending December 31, 2019 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 1

the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company

Company Limited (JSP) held the Board of Directors’ meeting no. 8/2560 on July 3, 2017, approved the Company to receive financial assistance from connected persons is as follows :- 1. Date of entering into